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The SNAT4 isoform of the system A amino acid transporter
is functional in human placental microvillous plasma
membrane
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Placental system A activity is important for the supply of neutral amino acids needed for fetal
growth. There are three system A isoforms: SNAT1, SNAT2 and SNAT4, but the contribution of
each to system A-mediated transport is unknown. Here, we have used immunohistochemistry
to demonstrate that all three isoforms are present in the syncytiotrophoblast suggesting each
plays a role in amino acid transport across the placenta. We next tested the hypothesis that the
SNAT4 isoform is functional in microvillous plasma membrane vesicles (MVM) from normal
humanplacentausingamethodwhichexploitstheuniquepropertyofSNAT4totransportboth
cationicaminoacidsaswellasthesystemA-speciﬁcsubstrateMeAIB.ThedatashowthatSNAT4
contribution to system A-speciﬁc amino acid transport across MVM is higher in ﬁrst trimester
placentacomparedtoterm(approx.70%and33%,respectively,P <0.01).Furtherexperiments
performedundermorephysiologicalconditionsusingintactplacentalvillousfragmentssuggest
acontributionofSNAT4tosystemAactivityinﬁrsttrimesterplacentabutminimalcontribution
atterm.Inagreement,WesternblottingrevealedthatSNAT4proteinexpressionishigherinﬁrst
trimester MVM compared to term (P <0.05). This study provides the ﬁrst evidence of SNAT4
activity in human placenta and demonstrates the contribution of SNAT4 to system A-mediated
transport decreases between ﬁrst trimester and term: our data lead us to speculate that at later
stages of gestation SNAT1 and/or SNAT2 are more important for the supply of amino acids
required for normal fetal growth.
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Duringintrauterinelifeanadequatesupplyofaminoacids
from the maternal circulation is essential for normal fetal
growth and development. In humans the maternal and
fetal circulations are separated by a polarized epithelium
in the placenta known as the syncytiotrophoblast. Amino
acid transfer across the syncytiotrophoblast is mediated
by a number of transporters found in the maternal-facing
microvillous plasma membrane (MVM) and fetal-facing
basalplasmamembrane(BM)(Moe,1995;Jansson,2001).
Each class of transporter is speciﬁc for a particular group
of amino acids and, based on competitive interactions
between amino acid substrates, at least 15 transport
systems for neutral, basic and acidic amino acids have
been identiﬁed in the syncytiotrophoblast analogous to
those described for other epithelia (Moe, 1995; Jansson,
2001).
S y s t e mAi saN a +-dependent transporter that actively
transports small, zwitterionic, neutral amino acids
with short, unbranched side chains such as alanine,
serine, and glutamine (Johnson & Smith, 1988). It
can also transport N-methylated amino acids such as
α-(methylamino)isobutyric acid (MeAIB) (Christensen
et al. 1965). This non-metabolizable amino acid analogue
has been used extensively to study system A activity
in the placenta (Mahendran et al. 1993; Novak et al.
1996; Jozwik et al. 1998; Jansson et al. 2003). Reduced
systemA activity has been demonstratedin MVM vesicles
isolated from placentas in which the fetus was growth
restricted (Dicke & Henderson, 1988; Mahendran et al.
1993; Glazier et al. 1997; Jansson et al. 2002). Whether
this represents a primary event in cases of intrauterine
growth restriction (IUGR) or is secondary to the growth
restriction is unknown. However, evidence from three
separateanimalstudiessuggestsreducedsystemAactivity
may be a cause of, rather than merely be associated with,
altered fetal growth. Inhibition of system A in pregnant
rats leads to fetal growth restriction (Cramer et al. 2002);
in a mouse model of IUGR (Constancia et al. 2002) and
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also in a dietary model of IUGR in the rat (Jansson et al.
2006), fetal growth restriction is preceded by alterations
in placental system A activity.
Molecular characterization of system A has revealed
that there are three highly homologous protein sub-
types of this Na+-coupled neutral amino acid transporter
known as SNAT1, SNAT2, and SNAT4, which are encoded
by three members of the SLC38 gene family (SLC38A1,
SLC38A2,a n dSLC38A4, respectively) (Hediger et al.
2004;Mackenzie&Erickson,2004).SLC38A2 isexpressed
ubiquitously in mammalian tissues (Hatanaka et al. 2000;
Sugawaraetal.2000a)andexpressionofSLC38A1hasbeen
showninvarioustissuesincludinghumanplacenta(Wang
etal.2000;Desforgesetal.2006).Functionally,SNAT1and
SNAT2 operate via similar mechanisms (Hatanaka et al.
2000;Wangetal.2000;Yaoetal.2000).SNAT4hasalower
substrateafﬁnityforneutralaminoacidsandMeAIBthan
SNAT1andSNAT2(Sugawaraetal.2000b;Hatanakaetal.
2001) and also has a unique ability amongst the other
system A isoforms to interact with cationic amino acids
in a Na+-independent manner (Hatanaka et al. 2001).
It was originally thought that SLC38A4/SNAT4 was a
liver-speciﬁc isoform (Hatanaka et al. 2001). However,
we have demonstrated expression in human placenta
(Desforges et al. 2006), and expression in rat (Novak et al.
2006)andmouseplacenta(Mizunoetal.2002;Smithetal.
2003) has also been documented.
TherelativecontributionofeachSNATisoformtototal
placental system A activity is not known; indeed it is
not certain that all three isoforms are active. We have
previously shown that SNAT4 protein is localized to the
MVM in human placenta at ﬁrst trimester and term
(Desforges et al. 2006), a location consistent with a role
in uptake of amino acids into the syncytiotrophoblast.
Our laboratory has also demonstrated SNAT2 protein
localization to the syncytiotrophoblast of term placenta
(Champion et al. 2004) but localization in ﬁrst trimester
is unknown and SNAT1 localization has yet to be
investigated.
System A activity in human placental MVM increases
between ﬁrst trimester and term (Mahendran et al. 1994)
coinciding with the increased fetal nutrient demand
as gestation advances and fetal growth rate accelerates.
Our previous investigations have shown SNAT4 protein
expressionincreasesinplacentalhomogenates(containing
amixtureofallplacentalcelltypes)betweenﬁrsttrimester
and term (Desforges et al. 2006) suggesting amino acid
transport by this isoform could be particularly important
for maintaining normal fetal growth. Furthermore, in
a mouse model of IUGR which displays alterations
in placental structure and function similar to those
found in human IUGR (Sibley et al. 2004), altered
placental MeAIB transport is speciﬁcally associated with
altered Slc38a4 mRNA expression (Constancia et al.
2005).
In the current study we have used immuno-
histochemistry to compare localization of SNAT1, SNAT2
andSNAT4inﬁrsttrimesterandtermhumanplacentaand
then examined any changes in the speciﬁc localization of
SNAT4 to the MVM between these two gestations using
Western blotting. We then performed experiments to test
the hypothesis that the SNAT4 isoform is functional in
normal human placenta and to estimate its contribution
to total system A activity both in the ﬁrst trimester
and at term. Deﬁnitively identifying the contribution of
SNAT4 to total system A transport in placenta, which
expresses all three SNAT isoforms, is complicated by
their overlapping substrate speciﬁcities. Therefore our
initial experiments were performed using isolated MVM
vesicles which allowed optimization of experimental
conditions, outside the normal physiological range, to
measure SNAT4 activity. Our experimental approach was
to exploit the unique property of SNAT4 to transport
cationic amino acids as well as MeAIB by measuring
the arginine-inhibitable component of MeAIB uptake by
MVMvesicles.Subsequently,experimentswereperformed
using intact placental villous tissue fragments to examine
whether SNAT4 activity could be measured under more
physiological conditions in tissue from ﬁrst trimester and
term pregnancy.
Methods
Chemicals
All chemicals were purchased from Sigma-Aldrich Co.
Ltd(Poole,UK)orVWRInternational(Lutterworth,UK)
unless otherwise stated.
Tissue acquisition and ethical approval
All tissue was obtained with written informed consent
as approved by the Central Manchester Research Ethics
Committee (REC Ref: 03/CM/031). Gestational age was
estimated from the date of last menstrual period and
conﬁrmed by ultrasound dating. First trimester placentas
(6–13weeks gestation) were obtained following elective
medical or surgical termination of pregnancy. Term
placentas(38–40weeksgestation)werecollectedfollowing
caesarean section or vaginal delivery from uncomplicated
singleton pregnancies.
Immunohistochemistry
Placentaltissuesamplesfromﬁrsttrimesterandtermwere
ﬁxed in 10% neutral buffered formalin overnight at 4◦C
before thorough washing in Tris buffered saline (TBS)
and parafﬁn embedding. Sections of 5μm were de-waxed
and rehydrated prior to antigen retrieval by microwaving
for 2×5min at 800W in 0.01 M citrate buffer (pH6.0).
Non-speciﬁc staining was prevented by quenching
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endogenous perxoidase activity with 3% aqueous H2O2,
followed by a 30min incubation with non-immune block
(10% normal swine serum, 2% normal human serum
(‘in-house’), 0.1% Tween-20 in TBS). Primary anti-
bodies (afﬁnity-puriﬁed rabbit IgG) were custom-made
(Eurogentec:Seraing,Belgium)usingthefollowingamino
acid sequences of the human system A isoforms as anti-
gen: SNAT1 – VPEDDNISNDSNDFT (residues 18–32);
SNAT2–SNLGKKKYETEFHPG(residues55–69);SNAT4
– YGEVEDELLHAYSKV (residues 391–405). Antibodies
were diluted to 1 μgml −1 in non-immune block and
appliedtosectionsovernightat4◦C.Fornegativecontrols,
and to ensure antibody speciﬁcity, primary antibodies
were preadsorbed with the appropriate puriﬁed antigenic
peptide (10× excess) overnight at 4◦C before applying to
serial sections at 1μgml −1. Following repeated washes
with TBS containing 0.6% Tween-20, antibody binding
was detected by sequential application of biotinylated
swine anti-rabbit IgG (Dako: Ely, UK; 1:200 dilution)
and avidin-peroxidase (20ngml−1), with the chromogen
diaminobenezidine, to produce a brown precipitate.
Sections were counterstained with Harris’ haematoxylin,
dehydrated and mounted with DPX.
Preparation of MVM vesicles
MVM vesicles were prepared using the method of Mg2+
precipitation and differential centrifugation as previously
described(Glazieretal.1988;Mahendranetal.1994)with
the modiﬁcation that Mg2+ concentration was increased
to 12 mM for ﬁrst trimester MVM. Once isolated, MVM
vesicles were suspended in intravesicular buffer (IVB:
30mM KCl, 110mM choline chloride, 20mM mannitol,
6.5mM Tris, and 13.5mM Hepes, pH7.4). MVM protein
concentration was determined by the method of Lowry
et al. (1951). Vesicle purity was assessed by measuring
enrichment of alkaline phosphatase activity as previously
described (Glazier et al. 1988; Mahendran et al. 1994).
Alkaline phosphatase enrichment factors (mean± S.E.M.)
forﬁrsttrimesterandtermMVMvesicles(n=6forboth)
were 18 ±2a n d1 9±2, respectively. Statistical analysis
revealed no signiﬁcant difference between the two groups
(P =0.82, Mann–Whitney U-test). All vesicles intended
for activity experiments were stored at 4◦Cp r i o rt o
measurement of amino acid uptake, performed within
48h of isolation. MVM vesicles intended for Western Blot
analysis were stored at −80◦C.
Western blot analysis
In order to compare SNAT4 protein expression in
MVM from ﬁrst trimester and term placenta, 30μg
protein was mixed at a ratio of 1:1 with loading buffer
(22% glycerol, pH6.8, 154mM SDS, 4.4 M urea, 0.002%
bromophenol blue, and 10% v/v 2-mercaptoethanol,
139mM Tris-HCl) and heat reduced for 5min at 95◦C.
BeWo choriocarcinoma cell homogenate was included
as a negative control for SNAT4 expression as shown
previously (Desforges et al. 2006) in order to conﬁrm
primary antibody speciﬁcity. Polyacrylamide gel electro-
phoresis was performed using 3% stacking gel and 10%
resolving gel. Proteins were then electrotransferred onto
nitrocellulose membrane. The membranes were blocked
for 1h at room temperature with 5% dried skimmed
milk powder in phosphate-buffered saline (PBS; 172mM
NaCl, 3.35 mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4,
pH7.4) and then washed for 3×5min in PBS–0.1%
Tween-20(PBS-T).ArabbitpolyclonaltoSNAT4(Abcam:
Cambridge, UK) was used at a 1:300 dilution in
PBS-T. Primary and HRP-conjugated goat anti-rabbit
secondary antibody (Dako, Ely, UK; 1:2000 dilution in
PBS-T) incubations were carried out for 1h at room
temperature. Immunoreactive signals were detected by
enhanced chemiluminescence (ECL). Following ECL, the
nitrocellulosemembranewasreprobedforβ-actin(mouse
anti-β-actin monoclonal, 1:1000 dilution) to conﬁrm
equal protein loading.
Measurement of total system A activity
in MVM vesicles
MVM vesicles from ﬁrst trimester and term placenta were
used at 5μgml −1 and 10μgml −1, respectively (diluted
in IVB). MVM vesicles were then incubated in 4μm
valinomycin, a potassium ionophore, for 1h at room
temperature as previously described (Ayuk et al. 2000)
before transport assays were performed. [14C]MeAIB
(0.4mM, Perkin Elmer) uptake was measured at room
temperature(21–24◦C) followingaddition of20μlM V M
vesicles to 100μl extravesicular buffer (EVB: 30mM KCl,
110mM NaCl, 20 mM mannitol, 14mM Tris, 6 mM Hepes,
pH8.5) by the method of rapid ﬁltration (Mahendran
et al. 1993, 1994; Ayuk et al. 2000). Experimental
conditions were modiﬁed to promote system A activity;
EVB composition achieved an inwardly directed Na+
gradient of ∼90mM across MVM plasma membranes
creating an optimal driving force for MeAIB transport
and an alkali pH of 8.5 was used to stimulate SNAT
activity (Hatanaka et al. 2001). [14C]MeAIB uptake in
the presence of 30mM MeAIB was also measured and
considered to be non-system A mediated because at this
high concentration of substrate it is predicted that all
three SNAT isoforms would be saturated. The difference
between total [14C]MeAIB uptake and uptake in the
presenceof30mMMeAIBwascalculatedtogiveameasure
of system A-speciﬁc uptake. Previous studies have shown
that [14C]MeAIB uptake by MVM after 30s provides
a reasonable estimate of initial rate (Mahendran et al.
C   2009 The Authors. Journal compilation C   2009 The Physiological Society64 M. Desforges and others J Physiol 587.1
1993; Kuruvilla et al. 1994; Glazier et al. 1997). Due to
the different experimental conditions used in the current
study, [14C]MeAIB uptakes over a 1min time course were
performed to ensure measurement at initial rate had been
achieved (see Results).
Measurement of SNAT4-speciﬁc activity
in MVM vesicles
In conjunction with the system A activity experiments
described above, [14C]MeAIB uptake by MVM vesicles
wasalsoperformedinthepresenceof10–30mMarginine.
The arginine-inhibitable component of system A-speciﬁc
[14C]MeAIB uptake by MVM vesicles was taken as a
measure of SNAT4-mediated activity as this is the only
system A isoform which supports this cationic amino
acid as a substrate (Hatanaka et al. 2001). SNAT4 has
a relatively low afﬁnity for MeAIB compared to the
other SNAT isoforms and therefore [14C]MeAIB was used
at a higher concentration (0.4mM)t h a ni np r e v i o u s
publications (0.165mM; Mahendran et al. 1994; Glazier
et al. 1997) to ensure contribution to uptake by SNAT4.
These experiments, performed under non-physiological
conditions(i.e.pH8.5,manipulatedtransmembraneNa+
gradient,andtheuseofsupraphysiologicalconcentrations
of arginine), were designed to conﬁrm SNAT4 activity
in MVM and provide an estimate of its contribution to
system A transport.
Measurement of total system A activity in placental
villous fragments
Villous fragments represent a more physiologically
relevant model than isolated MVM vesicles because tissue
architecture, cell-to-cell interactions, and intracellular
signalling pathways remain intact, important for the
maintenance of the normal driving forces for amino acid
transport. Therefore, system A activity measurements
were also performed using this model. Placental villous
fragments were dissected from ﬁrst trimester and term
placenta and rinsed in 1:3 mix of Dulbecco modiﬁed
Eagle medium (DMEM)/control Tyrode’s buffer (135mM
NaCl, 5 mM KCl, 1.8mM CaCl2,1 m M MgCl2,1 0 m M
Hepes, 5.6 mM glucose, pH7.4). Uptake of [14C]MeAIB
(10μm) into villous fragments over 20min was
carried out in control and Na+-free Tyrode’s buffer
(135mM choline chloride replaced NaCl, pH7.4) as pre-
viously described (Jansson et al. 2003; Ericsson et al.
2005; Greenwood & Sibley, 2006). The Na+-dependent
component of [14C]MeAIB uptake, representing system
A-speciﬁc uptake, was calculated by subtracting
[14C]MeAIB uptake in the absence of Na+ from uptake
in the presence of Na+. Fragment protein content (μg)
was determined using the method of Bradford (1976)
using a commercial kit (Bio-Rad Laboratories Ltd, Hemel
Hampstead, UK). Na+-dependent [14C]MeAIB uptake by
ﬁrst trimester and term fragments is expressed per mg
fragmentproteinover20min,atimepreviouslyconﬁrmed
to be at initial rate (Greenwood & Sibley, 2006).
Measurement of SNAT4-speciﬁc activity in placental
villous fragments
[14C]MeAIBuptakebyﬁrsttrimesterandtermfragments,
in both control and Na+-free conditions, was also
measured in the presence of 5mM MeAIB. The
Na+-dependent component of uptake in each condition
was calculated and expressed per mg protein over
20min. The transport function of SNAT1 and SNAT2
in human retinal pigment endothelial (HRPE) cells
is saturable with increasing concentrations of MeAIB
over the concentration range of 0.05–5mM (Hatanaka
et al. 2000; Wang et al. 2000) whereas the K m of
SNAT4 for MeAIB is 6.7mM. Therefore, any measurable
Na+-dependent [14C]MeAIB uptake by placental villous
fragments in the presence of 5mM MeAIB was taken to be
that speciﬁcally mediated by SNAT4. These experiments,
performed at physiological pH in intact placental tissue,
were designed to provide an estimate of placental SNAT4
activity in vivo.
RT-PCR
In order to examine SLC38A4 mRNA expression
in other human tissues besides placenta we used
RT-PCR. RNA (100ng) from various human tissues
including brain, stomach, lung, small intestine, heart,
kidney, liver (Ambion, Cambridge, UK) and placenta
(Stratagene), were reverse transcribed simultaneously
to generate cDNA, ensuring comparable reverse
transcription efﬁciency, and PCR was performed using
SLC38A4-speciﬁc primers (Desforges et al. 2006).
The thermal cycling conditions included an initial
denaturation step at 95◦C for 10min, followed by 40
cyclesofdenaturation,annealingandampliﬁcation(95◦C
for 30s, 58◦C for 1min, 72◦C for 30s). β-Actin mRNA
expressionwasalsoexaminedbyPCRinthesamesamples
as previously described (Lacey et al. 2005) to conﬁrm
cDNA integrity. SLC38A4 and β-actin ampliﬁcation
products were visualized by ethidium bromide staining
following agarose gel electrophoresis.
Statistical analysis
Following Western blotting, the mean intensity of signal
for immunoreactive species was assessed using Image
J software. These data are presented as median and
interquartile range and any difference between expression
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in ﬁrst trimester and term MVM was determined by a
Mann–Whitney U-test. Raw data of [14C]MeAIB uptake
by MVM vesicles over the 1min time course are pre-
sented as mean± S.E.M. Two-way ANOVA was used
to statistically analyse [14C]MeAIB uptake by MVM
vesicles in the presence of arginine over the 1min time
course. The calculated data of system A-speciﬁc and
SNAT4-mediated [14C]MeAIB uptake by MVM vesicles
and villous fragments are presented as median and
interquartile range. Any difference in system A-speciﬁc
or SNAT4-mediated [14C]MeAIB uptake between ﬁrst
trimester and term placenta was determined by a
Mann–Whitney U-test. All statistical analyses were made
using GraphPad Prism software and in all cases, P <0.05
was considered signiﬁcant.
Results
SNAT1, SNAT2 and SNAT4 localization in human
placenta
Figure 1 shows representative images from immuno-
histochemical analysis of SNAT1 (Fig.1A–F), SNAT2
(Fig.1G–L), and SNAT4 (Fig.1M–R) localization in
ﬁrst trimester (n=7) and term (n=6) placental tissue.
Immunostaining was predominantly localized to the
syncytiotrophoblast for all SNAT proteins. Cytoplasmic
staining was observed in all samples with heterogeneous
but intense MVM staining apparent for all three iso-
forms (Fig.1A, G and M). In ﬁrst trimester placenta,
the intensity of staining for SNAT1 was less in cyto-
trophoblaststhansyncytiotrophoblast(Fig.1AandB)but
the two cell types had similar levels of staining for SNAT2
(Fig.1GandH)andSNA T4(Fig.1O).SNAT1stainingwas
also detected in stromal Hofbauer cells and the vascular
endothelium of ﬁrst trimester placenta (Fig.1B and C),
whilst at term, this isoform of system A was exclusively
localized to syncytiotrophoblast (Fig.1D and E). SNAT 2
and4werealsopresentinendothelialcellsinﬁrsttrimester
placenta (Fig.1H and N), with faint staining persisting in
largerintermediateandstemvillousvesselsatterm(Fig.1L
and Q). Subpopulations of stromal cells were positive
for SNAT2 and 4 at both stages of gestation (Fig.1H, O
and Q). Spatial immunostaining patterns were consistent
in all samples examined, but considerable variation was
detected in staining intensity. Negative control sections
lacked detectable stain (Fig.1F, I and R).
SNAT4 protein expression in ﬁrst trimester
and term MVM
SNAT4proteinexpressionwascomparedinﬁrsttrimester
andtermMVMsamples(n=4foreach).Figure2Ashows
that a band representing protein with a molecular weight
corresponding to that of SNAT4 (∼70kDa) was present
in all MVM samples. There was no detectable immuno-
reactive signal in the BeWo sample used as a negative
control, conﬁrming antibody speciﬁcity. Densitometric
analysis of the blots shown in Fig.2A revealed that
SNAT4 protein expression was higher in ﬁrst trimester
MVM samples compared to term MVM (Fig.2C),
which is also visually apparent. To ensure this was not
attributable to unequal protein loading, following ECL
the nitrocellulose membrane was reprobed for β-actin
(Fig.2B). Densitometric analysis revealed there was no
signiﬁcant difference in β-actin protein expression in ﬁrst
t r i m e s t e rc o m p a r e dt ot e r mM V Ms a m p l e s( F i g . 2 D),
conﬁrming equal protein loading.
System A activity in ﬁrst trimester and term
MVM vesicles
Total [14C]MeAIBuptakebyﬁrsttrimesterandtermMVM
vesicles was linear (P <0.0001 forboth,linearregression)
over1min(seecontroluptakeinFig.3AandB)indicating
this measurement approximated to initial rate. Figure3C
showssystemA-speciﬁc[14C]MeAIBuptake(calculatedby
subtracting uptake in the presence of 30mM MeAIB from
control uptake) by term MVM vesicles was signiﬁcantly
higher than uptake by ﬁrst trimester vesicles at 30s.
Arginine-inhibitable MeAIB uptake by MVM vesicles
[14C]MeAIB uptake by term MVM was inhibited by
20mM and 30mM arginine (Fig.3B). Thirty millimolar
arginine had the most pronounced effect and, at this
concentration, also signiﬁcantly inhibited [14C]MeAIB
uptake by ﬁrst trimester MVM (Fig.3A). In experiments
using term MVM vesicles, the effect of 40mM and 50mM
arginine were also investigated but these did not cause
any further inhibition of [14C]MeAIB uptake (data not
shown). Inhibition of [14C]MeAIB uptake by 30mM
arginine was therefore used to calculate SNAT4-speciﬁc
activity in MVM vesicles. In order to ensure that the
inhibitory effect of 30mM arginine was speciﬁc for
MeAIB uptake, and not due to a general effect on amino
acid uptake by MVM vesicles, we performed additional
experiments to investigate the effect of 30mM arginine on
[3H]taurine uptake. Taurine is a speciﬁc substrate for the
Na+-dependent amino acid transporter system β which
is present in human placental MVM (Roos et al. 2004).
Thirty millimolar arginine did not inhibit [3H]taurine
uptake by MVM vesicles (data not shown) conﬁrming
the inhibitory effect of 30mM arginine was speciﬁc to
[14C]MeAIB uptake.
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Figure 1. Immunolocalization of SNAT1, SNAT2 and SNAT4 in ﬁrst trimester and term placentas
Representative photomicrographs for SNAT1 in ﬁrst trimester (A–C) and term placenta (D–E). Immunostaining is
predominantly in trophoblast cells (cytotrophoblast cells: CT and the syncytiotrophoblast: ST), with heterogeneous
intense staining on the microvillous membrane (MVM) (A and D). Additional staining was present in stromal
Hofbauer cells (asterisks) and vascular endothelium (V) in ﬁrst trimester (B and C), but not term (E inset),
placenta. SNAT2 exhibited a similar immunostaining pattern in ﬁrst trimester (G–I) and term (J–L) placenta, but
with endothelial staining present in vessels throughout pregnancy (H and L). Representative images for SNAT4
immunohistochemistry in ﬁrst trimester (M–O) and term (P–R) placenta, illustrate a similar localization. Immuno-
staining is predominantly syncytial, with MVM staining more pronounced in ﬁrst trimester (M)t h a nt e r m( P).
Negative controls are shown in F, I and R. Scale bars represent 50 μm; scale bar on image A refers to all images,
except image O.
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SNAT4-speciﬁc MeAIB uptake by MVM vesicles
The arginine-inhibitable component of system A-speciﬁc
[14C]MeAIBuptake,representingSNAT4-mediatedtrans-
port (mean± S.E.M.), in ﬁrst trimester and term vesicles
was 0.083±0.014 and 0.06±0.01pmol (mg protein−1
(30s)−1,respectively(P =0.24,unpairedt test).Figure3D
shows that when these data are expressed as a percentage
of system A-speciﬁc [14C]MeAIB uptake, the SNAT4
contribution to total system A activity was signiﬁcantly
higher in ﬁrst trimester MVM vesicles compared to term
vesicles under these experimental conditions.
MeAIB uptake by human placental villous fragments
Figure4AshowsthatNa+-dependent[14C]MeAIBuptake,
representing system A-mediated transport, by term
placental villous fragments is signiﬁcantly higher than
uptake by ﬁrst trimester fragments. This increase could
not be attributed to differences in fragment size
(Greenwood & Sibley, 2006) as the protein content
of ﬁrst trimester and term placental villous fragments
was comparable (mean± S.E.M.=501.8±46.3 and
625.7±45.6μg, respectively, unpaired t test, P =0.07).
SNAT4-speciﬁc MeAIB uptake by villous fragments
In the presence of 5mM MeAIB, Na+-dependent
[14C]MeAIB uptake by term villous fragments was not
signiﬁcantly different from zero (−1.1±2.5pmol(mg
Figure 2. SNAT4 expression in ﬁrst trimester and term MVM
Western blot of 4 ﬁrst trimester (F) and 4 term (T) MVM samples probed for A, SNAT4 and B, β-actin using
BeWo (B) as a negative control for SNAT4 expression. After 2 s exposure a single immunoreactive signal was
observed in all lanes at the expected size of ∼45 kDa for β-actin. After 5 min exposure a single immunoreactive
signal representing SNAT4 protein was observed in all MVM samples at ∼70 kDa. C and D, bar chart to show
densitometric analysis of SNAT4 (C)a n dβ-actin (D) protein expression in ﬁrst trimester and term MVM samples
(median and interquartile range, n = 4 for each group). ∗P < 0.05, Mann–Whitney U-test.
protein)−1 (20min)−1, P =0.38, Wilcoxon’s signed rank
test, n=3) whereas Na+-dependent [14C]MeAIB uptake
byﬁrsttrimestervillousfragmentsinthepresenceof5mM
MeAIB was 43.9±12.7pmol(mg protein)−1 (20min)−1
(Fig.4B). These data suggest that, under physiological
conditions, there is a contribution of SNAT4 to system
A-mediated transport in ﬁrst trimester placenta, whereas
in term placenta, SNAT4 activity is minimal.
SLC38A4 mRNA expression in human tissue
The ampliﬁcation product generated following SLC38A4
PCR was visualized as a single band of appropriate size
(152bp) following agarose gel electrophoresis (Fig.5A).
The data reveal SLC38A4 mRNA is expressed in all
human tissues examined, including human placenta and
liver as positive controls (Desforges et al. 2006). The
ampliﬁcation product generated following β-actin PCR
wasalsovisualizedonagarosegel(Fig.5B)andconﬁrmed
cDNA integrity in all samples.
Discussion
We have used immunohistochemical staining to
conﬁrm all three SNAT isoforms are present in the
syncytiotrophoblastMVMofhumanplacentaduringﬁrst
trimester and at term suggesting each has the potential to
mediate amino acid transport from maternal blood in the
intervillousspace,intotheplacenta,andtowardsthefetus.
We proceeded to design experiments to explore whether
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the SNAT4 isoform of system A is functional in human
placental MVM during ﬁrst trimester and at term. This
studyistheﬁrsttoinvestigatetheactivityofasingleSNAT
isoform in the placenta, or in any tissue, which expresses
all three system A isoforms.
Western blotting revealed higher SNAT4 protein
expression in ﬁrst trimester MVM compared to term.
SNAT4 protein expression was also considerably variable
between term MVM samples. The emerging pattern of
SNAT4 expression and activity in human placenta across
gestation appears to be quite complex. We have pre-
viously shown SNAT4 protein expression is lower in
ﬁrst trimester human placental homogenates, comprising
m a n yc e l lt y p e s ,c o m p a r e dt ot e r m( D e s f o r g e set al.
2006).However,ourcurrentWesternblottingdatasuggest
that during ﬁrst trimester a greater proportion of the
Figure 3. [14C]MeAIB uptake by MVM vesicles
A, the effect of arginine on [14C]MeAIB uptake by ﬁrst trimester (FT) MVM and B, term MVM vesicles (n = 6
in each group). Data presented are mean ± S.E.M. and statistical analysis by 2-way ANOVA. Symbols shown are;
, control; , + 10 mM arginine; , + 20 mM arginine; , + 30 mM arginine; •, + 30 mM MeAIB. ∗∗P < 0.01,
∗∗∗∗P < 0.0001 versus control. [14C]MeAIB uptake in the presence of 30 mM MeAIB was signiﬁcantly lower
than [14C]MeAIB uptake in all other conditions (P < 0.0001) and was considered non-system A-mediated due to
saturation of all isoforms by this high concentration of substrate. In all conditions [14C]MeAIB uptake signiﬁcantly
increased with time (P < 0.0001). C, comparison of system A-mediated [14C]MeAIB uptake (calculated by sub-
tracting [14C]MeAIB uptake in the presence of 30 mM MeAIB from total [14C]MeAIB uptake) by FT and term MVM
after 30 s. Data presented are median and interquartile range, n = 6 in each group, ∗P < 0.05 (Mann–Whitney
U-test). D, arginine-inhibitable component of system A activity (expressed as a percentage of system A-mediated
[14C]MeAIB uptake) by FT and term MVM. Data presented are median and interquartile range, n = 6 in each
group, ∗∗ P < 0.01 (Mann–Whitney U-test).
SNAT4 protein pool is localized to the MVM. Consistent
with this observation, immunohistochemical detection
of SNAT4 shows strong staining in the cytoplasm of
the syncytiotrophoblast of term placental tissue whereas
in ﬁrst trimester syncytiotrophoblast there is relatively
more MVM staining of the syncytiotrophoblast layer.
This accords with evidence from other cell types that
shows preformed SNAT proteins are stored in cyto-
plasmic compartmentsbefore translocation to the plasma
membrane takes place (Hundal et al. 1994; Ling et al.
2001; Hyde et al. 2002). As SNAT4 protein was also
localized to fetal blood vessels, which are widespread at
term but poorly developed during the ﬁrst trimester, this
may contribute to the higher SNAT4 protein expression
previously observed in term placental homogenates
(Desforges et al. 2006).
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Figure 4. [14C] MeAIB uptake by placental villous fragments
A,N a +-dependent [14C]MeAIB uptake by ﬁrst trimester (FT) and term placental villous fragments (n = 16 in
each group). These data represent system A-mediated transport of [14C]MeAIB and are presented as median and
interquartile range. System A activity is signiﬁcantly higher at term compared to during ﬁrst trimester (∗P < 0.05,
Mann–Whitney U-test). B,N a +-dependent [14C]MeAIB uptake by ﬁrst trimester (n = 6) and term (n = 3) villous
fragments in the presence of 5 mM MeAIB, representing SNAT4-mediated activity. SNAT4-mediated activity is
signiﬁcantly lower at term compared to during ﬁrst trimester (∗P < 0.05, Mann–Whitney U-test).
Following consideration of the substrate speciﬁcity
and kinetic characteristics of SNAT4 we deﬁned
SNAT4-mediated transport by MVM vesicles as
arginine-inhibitable [14C]MeAIB uptake. The strategy of
using the cationic amino acid arginine as a SNAT4 sub-
strate is confounded by its speciﬁcity also for the amino
acid transporter systems y+ and y+Lw h i c ha r ea c t i v ei n
MVM of ﬁrst trimester and term human placenta (Ayuk
etal.2000).Howeverthesetwocationicaminoacidtrans-
porter systems do not support MeAIB as a substrate
(Fei et al. 1995; Pfeiffer et al. 1999; Broer et al. 2000)
strengthening the rationale for using this competitive
inhibition approach. In the current study, experimental
conditions using MVM vesicles were designed to promote
MeAIB transport by SNAT4: the pH and the Na+ gradient
set across MVM vesicles were optimized to promote
neutral amino acid transport by SNAT4 (Hatanaka
et al. 2001). Furthermore, we used a relatively high
concentration of [14C]MeAIB (0.4mM) compared to pre-
vious studies of system A activity in placenta (0.165mM)
inordertoachievecontributiontotransportacrossMVM
by SNAT4. This was based on functional expression
studies of the cloned SNAT transporters in HRPE cells,
which demonstrate SNAT4 has a relatively low afﬁnity
for MeAIB (K m =6.7mM) compared to the other SNAT
Figure 5. Ampliﬁcation products for SLC38A4 (A)
and β-actin (B) PCR visualized on agarose gel using
a 50-bp ladder
The human tissue samples include: Br, brain; St,
stomach; Lu, lung; SI, small intestine; H, heart; Ki,
kidney; Pl, term placenta; Li, liver; –RT, negative control
(no reverse transcriptase enzyme); NTC, no template
control. SLC38A4 mRNA was expressed in all tissues.
isoforms(K m =0.89and0.39mMforSNAT1andSNAT2,
respectively)(Hatanakaetal.2000,2001;Wangetal.2000).
In agreement with previous observations (Mahendran
et al. 1994), and using a modiﬁed assay system, we have
shown that total system A activity in placental MVM is
higher at term than duringﬁrst trimester.Consistentwith
these observations, we have also demonstrated increased
placental system A activity between ﬁrst trimester and
term using freshly isolated villous fragments. In contrast,
Ericsson et al. (2005) reported no signiﬁcant difference in
Na+-dependenttransportofMeAIBintovillousfragments
between ﬁrst trimester and term. The reason for these
differing observations could be related to the size of
fragments used (Greenwood & Sibley, 2006) or due to the
concurrencyofourexperimentsincontrasttotheEricsson
et al. (2005) study, which compared ﬁrst trimester data to
term data arising from an earlier study by Jansson et al.
(2003).
Despite there being increased total system A activity
in human placenta between ﬁrst trimester and term, our
data demonstrate that SNAT4 activity in ﬁrst trimester
M V Mi sc o m p a r a b l et oi nt e r mM V M ;h o w e v e r ,t h e
contribution of SNAT4 to total system A activity is lower
i nt e r mM V Mc o m p a r e dt oﬁ r s tt r i m e s t e r .C o l l e c t i v e l y
these data indicate, ﬁrstly, that this broader speciﬁcity
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isoform has a particularly important role in delivering
amino acids to the fetus in early pregnancy, and secondly,
that the gestational increase in system A transporter
activity between ﬁrst trimester and term is likely to be
mediated by up-regulation of SNAT1 and/or SNAT2. It
will therefore be important to determine the contribution
of these particular SNAT isoforms to system A transport
acrossMVMduringnormalpregnancyinordertofurther
understand the complex gestational changes associated
with this transporter.
MVM vesicles lack the intracellular regulatory
components present in intact placental tissue which
inﬂuence amino acid transporter activity. Therefore, in
vivo,theabsolutecontributionofSNAT4tototalsystemA
activity may be somewhat different from that suggested
by the vesicle data (i.e. approximately 70% in ﬁrst
trimester compared to 33% at term). To address this
issue we performed experiments designed to measure
SNAT4 activity under more physiological conditions in
villous fragments from human placenta. Any measurable
Na+-dependent uptake of [14C]MeAIB (0.01mM)i n
the presence of 5mM MeAIB was considered to be
SNAT4-mediated system A activity based on kinetic data
showingthatSNA T1andSNA T2activityissaturableatthis
concentrationofMeAIB(Hatanakaetal.2000;Wangetal.
2000).Itisthereforeinterestingthattherewasmeasurable
Na+-dependent uptake of [14C]MeAIB by ﬁrst trimester
villous fragments but not by term villous fragments in the
presence of 5mM MeAIB. These data suggest there is little
or no SNAT4-mediated transport of neutral amino acids
in term placenta and higher SNAT4-mediated transport
in ﬁrst trimester placenta, a trend which agrees well with
the MVM vesicle data. Expression of SNAT4 protein in
term MVM does suggest a functional role in amino acid
transport and therefore it is reasonable to speculate that
SNAT4couldmediatethetransportofcationic,ratherthan
neutral,aminoacidsatterm.Althoughthisisapossibility,
our laboratory has previously demonstrated evidence for
onlytwotransportsystemsforcationicaminoacidsinthe
MVM of term human placenta, identiﬁed to be systems
y+ and y+L( A y u ket al. 2000).
Numerous studies have shown there is reduced MVM
system A activity in pregnancies associated with IUGR
compared to normal pregnancy (Dicke & Henderson,
1988; Mahendran et al. 1993; Glazier et al. 1997; Jansson
et al. 2002). In a mouse model of IUGR which displays
alterations in placental structure and function that are
similar to those found in human IUGR (Sibley et al.
2004), reduced placental system A activity is speciﬁcally
associated with altered Slc38a4 expression (Constancia
et al. 2005). Furthermore, ablation of the major placental
promoter for Slc38a4 in mice is associated with fetal
growthrestriction(G.KelseyandM.Constˆ ancia,personal
communication). These data suggest the SNAT4 isoform
of system A plays an important role in the provision
of amino acids for normal fetal growth in mice. In
mouse placenta Slc38a4 is imprinted, being paternally
expressed (Mizuno et al. 2002; Smith et al. 2003),
which further suggests a role in promoting fetal growth
(Coan et al. 2005; Fowden et al. 2006). It will therefore
be interesting to investigate placental SLC38A4/SNAT4
expression in human IUGR and measure SNAT4 activity
across MVM using the methods described in this study,
in conjunction with the fragment experiments also
described, to determine any differences from normal
pregnancy. One study has shown placental SLC38A1
and SLC38A2 mRNA expression in human IUGR is
comparable to that in normal pregnancies but the
authors did not investigate SLC38A4 expression (Malina
et al. 2005). As shown in the current study, there is
broad distribution of SNAT isoforms in human placenta
highlighting the importance of performing functional
assays in parallel to expression studies. Development of
isoform-speciﬁc knockdown protocols for each of the
three SNAT isoforms in cytotrophoblast cells and intact
placental tissue will greatly assist in deﬁning the relative
contribution of each to placental system A activity over
gestation and in relation to fetal growth anomalies.
SLC38A4 mRNA is expressed in various tissues from
mouse (Mizuno et al. 2002) and also cattle (Zaitoun
& Khatib, 2006). In the current study we demonstrated
expression of SLC38A4 in various human tissues
previously shown to be devoid of SLC38A4 expression
(Hatanaka et al. 2001). These observations conﬁrm this
isoform of system A should no longer be considered
liver-speciﬁc, and suggest it may be important for
the transport of amino acids required for metabolism
and protein synthesis in a variety of tissues. The
experimental approaches described in this study for
measuring SNAT4 activity could be applied to other
human tissues besides placenta. This would be useful for
identifying the involvement of SNAT4 in altered system
A activity associated with certain diseases. For example
in diabetes there is increased system A activity in the
liver (Handlogten & Kilberg, 1984; Rosenthal et al. 1985;
Schenerman&Kilberg,1986),akeygluconeogenicorgan.
As gluconeogenesis primarily involves the conversion
of amino acids and the recycling of glucose-derived
carbon skeletons to glucose (Felig, 1975), with alanine an
important glucose precursor, an altered system A activity
in the liver could impact on the rate of alanine-supported
gluconeogenesis and inﬂuence circulating glucose levels.
SLC38A2 and SLC38A4 mRNA expression is increased
in experimentally induced diabetic liver (Varoqui &
Erickson, 2002). It would therefore be interesting to
investigatewhethertheincreasedhepaticsystemAactivity
in diabetes can be attributed to increased SNAT4 activity
usingsimilarapproachestothosedescribedinthisstudy.
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